The Australian PM recently announced adults of all ages would be eligible to get the AstraZeneca vaccine, despite conflicting health advice
Australia’s government has made the AstraZeneca vaccine available to people under 60. While the Federal government has announced the change, under 40s won’t be able to book for a few days while the system is updated.
AstraZeneca is the country’s preferred vaccine for people over 60 based on the health advice from the Australian Technical Advisory Group on Immunisation.
The ATAGI says for those aged 60 and above, the benefits of preventing COVID-19 with the AstraZeneca vaccine outweigh the risk of TTS. Also, people who have already been vaccinated with their first dose should proceed with their second, even if they’re younger than 60.
However, there are some rare but serious complications for vaccinated young people. So, what are these potential complications? And do they outweigh the risks of contracting Covid?
“If you wish to get the AstraZeneca vaccine, then we would encourage you to go and have that discussion with your GP.”
Australian Prime Minister Scott Morrison
Head of the COVID-19 Vaccine Taskforce, Lieutenant General John Frewen, told Nine they were working to update the booking system now.
“We’ll be onto it as quickly as we can, and I really think people should be able to start making arrangements, you know, in the days ahead, and in the next couple of weeks I hope to see the effect of these new policies,” he said.
Talk to your GP about potential health risks
President of the Australian Medical Association Dr Omar Khorshid said people should speak to their GP about the risks of AstraZeneca.
“GPs are in the best position to assess risk and talk to patients about vaccines.
“Any Australians under the age of 60 wanting to have AstraZeneca, talk to your GP who can advise on the risks as outlined by ATAGI and in relation to their own health.
What are the chances of getting a blood clot from AstraZeneca?
Medical professionals have linked the AstraZeneca vaccine to a blood clotting disorder called thrombosis with thrombocytopenia syndrome (TTS).
TTS is extremely rare and treatable. It’s likely to occur with the first dose of AstraZeneca. However, the rate of clotting incidents is low.
TSS symptoms can include a severe headache that doesn’t go away, abdominal pain, blurred vision, and leg pain or swelling. They appear four to 30 days after receiving the AstraZeneca vaccine, with a peak time of six to 14 days.
In Australia, the mortality rate for TTS is about 4 percent, which is about a 1 in a 2 million chance of death.
This is about the same likelihood of being killed by lighting.
For people aged under 50, there have been 3.1 cases of clotting per 100,000 first doses. Medical professionals can treat the condition with blood-thinning medication.
Natasha is an Associate Producer at ticker NEWS with a Bachelor of arts from Monash University. She has previously worked at Sky News Australia and Monash University as an Online Content Producer.
Insights on adapting to rapid change and empowering gig workers
In a rapidly evolving work landscape, microlearning platforms are crucial for the gig economy. Helen Doukas, CEO of Nuvo Work, emphasises how technology is enabling flexible work opportunities and necessitating agile learning methods.
She predicts that the gig economy will continue to grow, driven by a demand for skill-sharing and collaborative learning. Nuvo Work’s expertise-sharing platform is leading this transformation, providing gig workers with tailored resources to enhance their skills. By fostering continuous learning, Nuvo Work is helping create a more adaptable and prepared workforce for the future.
Navigating the Challenges of Generative AI in Election Communications
With the 2024 election approaching, the use of artificial intelligence in political campaigns is raising significant concerns about regulation and misinformation. At least 26 states have enacted bills to regulate AI-generated content, while others remain inactive.
As deepfakes and manipulated videos become more prevalent, there are increasing calls for comprehensive federal regulations. Recent instances of AI-generated misinformation have already influenced political campaigns, underscoring the urgent need for effective measures to safeguard election integrity.
Israel has widened its military operations in Lebanon, launching a deadly airstrike in the northern region. The attack, which targeted a house sheltering displaced families, killed at least 21 people, leaving eight others injured, according to health officials. Rescue workers are still searching through the rubble for survivors.
This shift marks a significant escalation, as Israel had previously focused its strikes on the south, the Bekaa Valley, and Beirut’s outskirts. Meanwhile, millions of Israelis are taking cover from cross-border rocket fire as the violence intensifies. Israel has also ordered the evacuation of 25 villages in southern Lebanon. Prime Minister Netanyahu vowed to continue targeting Hezbollah “without mercy,” even extending operations to Beirut. In eastern Lebanon, civilians like Jalal Ferhat and his family have fled toward the Syrian border in a desperate attempt to escape the worsening conflict.
